Validation of the Scottish Inflammatory Prognostic Score (SIPS) in NSCLC Patients Treated with First-Line Pembrolizumab.

Saved in:
Bibliographic Details
Title: Validation of the Scottish Inflammatory Prognostic Score (SIPS) in NSCLC Patients Treated with First-Line Pembrolizumab.
Authors: Gomez-Randulfe, Igor1 (AUTHOR) igor.gomezrandulfe@nhs.net, Gomes, Fabio1 (AUTHOR), MacKean, Melanie2 (AUTHOR), Phillips, Iain2,3 (AUTHOR), Stares, Mark2,3 (AUTHOR) mark.stares@ed.ac.uk
Source: Cancers. Nov2024, Vol. 16 Issue 22, p3833. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers16223833